Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  JAMA Neurology

• Publication date

  2014-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/jamaneurol.2014.445PMID 24756381PMCID PMC4051849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Linear Mixed-Effects Models using 'Eigen' and S4

  2015cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.

  2013cited by this paper
• Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

  2013cited by this paper
• Increase in Cerebrospinal Fluid F2-Isoprostanes is Related to Cognitive Decline in APOE ε4 Carriers

  2013cited by this paper
• Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

  2013cited by this paper
• A general and simple method for obtaining R2 from generalized linear mixed‐effects models

  2013cited by this paper
• Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI

  2013cited by this paper
• Cerebrospinal Fluid Biomarkers Mirror Rate of Cognitive Decline

  2013cited by this paper
• Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting

  2013cited by this paper
• Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism.

  2013cited by this paper
• Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

  2012cited by this paper
• Vascular burden and Alzheimer disease pathologic progression

  2012cited by this paper
• Adult Changes in Thought study: dementia is an individually varying convergent syndrome with prevalent clinically silent diseases that may be modified by some commonly used therapeutics.

  2012cited by this paper
• Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.

  2012cited by this paper
• The Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment.

  2012cited by this paper
• Amyloid-β42 is Associated with Cognitive Impairment in Healthy Elderly and Subjective Cognitive Impairment

  2011cited by this paper
• The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

  2011cited by this paper
• Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project.

  2011cited by this paper
• P1‐108: Cerebrospinal fluid biomarkers, education, brain volume and future cognition

  2011cited by this paper
• Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.

  2011cited by this paper
• IC‐02‐04: Ordering of Alzheimer's disease biomarkers

  2011cited by this paper
• Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort.

  2011cited by this paper
• Oxidative Damage in Ischemic Stroke Revealed Using Multiple Biomarkers

  2011cited by this paper
• Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

  2010cited by this paper
• Halstead‐Reitan Neuropsychological Test Battery

  2010cited by this paper
• White matter changes and diabetes predict cognitive decline in the elderly

  2010cited by this paper
• Associations Between Microinfarcts and Other Macroscopic Vascular Findings on Neuropathologic Examination in 2 Databases

  2009cited by this paper
• Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

  2009cited by this paper
• Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.

  2009cited by this paper
• Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo

  2009cited by this paper
• Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models.

  2008cited by this paper
• CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment

  2007cited by this paper
• CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study.

  2007cited by this paper
• Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

  2007cited by this paper
• Using verbal fluency to detect very mild dementia of the Alzheimer type.

  2006cited by this paper
• Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha- or gamma-tocopherol.

  2005cited by this paper
• Safety and Acceptability of the Research Lumbar Puncture

  2005cited by this paper
• Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by α- or γ-tocopherol

  2005cited by this paper
• Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate.

  2004cited by this paper
• The Halstead-Reitan Neuropsychological Test Battery.

  2000cited by this paper
• Mixed effect models of longitudinal Alzheimer's disease data: a cautionary note.

  2000cited by this paper
• Patterns of cognitive decline in aged rhesus monkeys.

  1997cited by this paper
• Spurious Correlation and the Fallacy of the Ratio Standard Revisited

  1993cited by this paper
• The Wechsler Memory Scale—Revised

  1990cited by this paper
• Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

  1990cited by this paper
• Wechsler memory scale-revised

  1988cited by this paper
• A Simple Sequentially Rejective Multiple Test Procedure

  1979cited by this paper

• The double-edged sword: Psychedelic-assisted therapy and entrepreneurial well-being, an early conceptual framework

  2025cites this paper
• Prevalence and risk factors of cognitive frailty among pre‐frail and frail older adults in nursing homes

  2024cites this paper
• Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment

  2024cites this paper
• Adipocyte-Derived Small Extracellular Vesicles from Patients with Alzheimer Disease Carry miRNAs Predicted to Target the CREB Signaling Pathway in Neurons

  2023cites this paper
• NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-β and Tau Levels in the Continuum of Alzheimer’s Disease

  2023cites this paper
• Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: A monozygotic twin study

  2022cites this paper
• Structural and Functional Brain Connectivity Uniquely Contribute to Episodic Memory Performance in Older Adults

  2022cites this paper
• Behaviors of Water Intake, Hydration Status, and Related Hydration Biomarkers among Physically Active Male Young Adults in Beijing, China: A Cross-Sectional Study

  2022cites this paper
• Water intake, hydration status and related hydration biomarkers among physically active male young adults in Beijing, China: a cross-sectional study

  2022cites this paper
• Association of F2-isoprostane levels with Alzheimer's disease in observational studies: a systematic review and meta-analysis.

  2021cites this paper
• Psychomotor Speed Predicts Outcome in Patients with Acute Meningitis and Encephalitis: A Prospective Observational Study

  2021cites this paper
• Metabolic Profiling and Quantitative Analysis of Cerebrospinal Fluid Using Gas Chromatography–Mass Spectrometry: Current Methods and Future Perspectives

  2021cites this paper
• Cross-sectional Associations of Tau Protein Biomarkers with Semantic and Episodic Memory in Older Adults Without Dementia: A Systematic Review and Meta-analysis.

  2021influential citation
• Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum

  2021cites this paper
• Cross-sectional associations of amyloid burden with semantic cognition in older adults without dementia: A systematic review and meta-analysis

  2020cites this paper
• The Role of Urine F2-isoprostane Concentration in Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Haemorrhage—A Poor Prognostic Factor

  2020cites this paper
• Higher plasma levels of F2-isoprostanes are associated with slower psychomotor speed in healthy older adults

  2019cites this paper
• Cognitive trajectory changes over 20 years prior to dementia diagnosis : a large cohort study

  2019cites this paper
• Medial temporal lobe white matter pathway variability is associated with individual differences in episodic memory in cognitively normal older adults.

  2019cites this paper
• Sex-specific genetic predictors of Alzheimer’s disease biomarkers

  2018cites this paper
• Impaired verbal episodic memory in healthy older adults is marked by increased F2-Isoprostanes.

  2018cites this paper
• Subtle Cognitive Impairment and Alzheimer’s Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects

  2018cites this paper
• Relationship Between Depressive Symptoms and Activity of Daily Living Dependence in Older Japanese: The Kurabuchi Study

  2017cites this paper
• Cognitive Variability Predicts Incident Alzheimer’s Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker

  2017cites this paper
• Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults

  2017cites this paper
• Cognitive Trajectory Changes Over 20 Years Before Dementia Diagnosis: A Large Cohort Study

  2017cites this paper
• Nutrition for the ageing brain: Towards evidence for an optimal diet.

  2017cites this paper
• Reactive Oxygen Species and Protein Oxidation in Neurodegenerative Disease

  2016cites this paper
• Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer’s Disease in Cognitively Normal Individuals 10 Years Prior

  2016cites this paper
• Elevated plasma F2-isoprostane levels in schizophrenia.

  2016cites this paper
• Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.

  2016cites this paper
• Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’

  2016cites this paper
• utrition for the ageing brain: Towards evidence for an optimal diet

  2016cites this paper
• Methods for Biomarker Analysis

  2015cites this paper
• Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.

  2015cites this paper
• Current development in non-enzymatic lipid peroxidation products, isoprostanoids and isofuranoids, in novel biological samples

  2015cites this paper
• Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease

  2015cites this paper
• The isoprostanes--25 years later.

  2015cites this paper
• Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study

  2015cites this paper
• The Effects of Aging, Malingering, and Traumatic Brain Injury on Computerized Trail-Making Test Performance

  2015cites this paper
• Alzheimer disease Cerebrospinal Fluid biomarker in Cognitively Normal Subjects : Multicenter 1 Study 2

  2015cites this paper
• Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.

  2015cites this paper
• The evolution of preclinical Alzheimer's disease: implications for prevention trials.

  2014cites this paper
• Cerebrospinal fluid levels of Alzheimer’s disease biomarkers in middle-aged patients with type 1 diabetes

  2014cites this paper